... Nov 19
Clinical evidence for this device demonstrates safety and efficacy for people suffering from mitral regurgitation... Nov 18
Under the terms of the transaction, Catalent acquires Bone Therapeutics’ cell therapy manufacturing subsidiary, SCTS, for gross proceeds of €12 million... Nov 18
Under the terms of the agreement, the companies plan to initiate a Phase 1/2 study evaluating the combination of tafasitamab, plamotamab and lenalidomide ... Nov 13
This work will allow Vapogenix to meet with the U.S. Food and Drug Administration (FDA) to finalize an Investigational New Drug (IND)-application... Nov 13
Dolutegravir is the first integrase inhibitor available as a dispersible tablet for children... Nov 13
Intranasal vaccine would be first of it's kind if approved... Nov 13
Tuznue is a mAb biosimilar to Roche’s Herceptin (trastuzumab)... Nov 13
Celgene, sells Pomalidomide Capsules under the Brand name POMALYST, for the treatment of patients suffering from multiple myeloma cancer... Nov 13
... Nov 12
This unique model of collaboration between Transcenta and Merck brings the teams together in real time ... Nov 12
Tacrolimus Capsules USP are indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney or heart transplants... Nov 12
CALAVI did not meet the primary endpoint of increasing the proportion of patients who remained alive and free of respiratory failure... Nov 12
Glenmark has been granted final approval by the U.S. FDA for Tacrolimus Capsules USP, the generic version of Prograf Capsules, of Astellas Pharm US, ... Nov 11
AdCovid is its single-dose Intranasal vaccine candidate for COVID-19... Nov 10
Finerenone for patients with chronic kidney disease and type 2 diabetes... Nov 10
LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
AstraZeneca and Amgen today announced positive results from the new medicine tezepelumab in patients with severe, uncontrolled asthma.... Nov 10
Since 2015 Insilico Medicine pioneered the field of generative adversarial networks and reinforcement learning for generative chemistry and generative biology... Nov 10
... Nov 10
... Oct 01
-Advertisements-
Saturday, June 15, 2024
